Open Ledger
Hims Hers financials in Beancount
Hims Hers keeps 7 recorded periods through FY2026Q3 as a balanced Beancount ledger — inspect the figures below, then open the live books.
Updated
Latest figures
- Revenue
- $890.4M (890.373 MUSD)
- Net income
- -$33M (-33.04 MUSD)
- Net margin
- -3.7%
Recorded history
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2021 | December 31, 2021 | $271.9M (271.878 MUSD) | -$107.7M (-107.659 MUSD) |
FY2022 | December 31, 2022 | $526.9M (526.916 MUSD) | -$65.7M (-65.678 MUSD) |
FY2023 | December 31, 2023 | $872M (872 MUSD) | -$23.5M (-23.546 MUSD) |
FY2024 | December 31, 2024 | $1.5B (1,476.514 MUSD) | $126M (126.038 MUSD) |
FY2025 | December 31, 2025 | $2.3B (2,347.637 MUSD) | $128.4M (128.365 MUSD) |
Recorded revenue and net income in MUSD (Quarter periods).
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2026Q2 | June 30, 2026 | $753.2M (753.214 MUSD) | -$86.3M (-86.29 MUSD) |
FY2026Q3 | September 30, 2026 | $890.4M (890.373 MUSD) | -$33M (-33.04 MUSD) |
Coverage
Coverage7
FY2021FY2022FY2023FY2024FY2025FY2026Q2FY2026Q3
Earnings analyses
More companies in this sector
- Eli LillyEli Lilly Q3 2026 Earnings: Revenue Up 39%, EPS Up 16% After a $4.2B Acquired R&D Charge
- Novo NordiskNovo Nordisk Q3 2026 Earnings: Sales Up 4%, Reported Profit Down 16% on DKK 8.7B of Write-Downs
- Healthcare Services GroupHealthcare Services Group Q3 2026 Earnings: Segment Profit Up 45% as Net Income Falls 42%